• About Us
  • Our Approach
    • Discovery Platform
  • Pipeline
    • HMBD-001
    • HMBD-002
    • HMBD-501
  • News
  • Careers

What are you looking for?

Hummingbird Bioscience
Hummingbird Bioscience
Hummingbird Bioscience
  • About Us
  • Our Approach
    • Discovery Platform
  • Pipeline
    • HMBD-001
    • HMBD-002
    • HMBD-501
  • News
  • Careers

    hbs-admin

  • All
  • Announcements
  • News
  • Publications & Posters
    • Announcements
    • Announcements 2023

    Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program

    Continue Reading
    • Announcements
    • Announcements 2022

    Caris Life Sciences and Hummingbird Bioscience Enter Into Collaboration to Advance Clinical Development of Anti-HER3 Therapy

    Continue Reading
    • Publications & Posters
    • Publications & Posters - 2022

    SITC 2022: Anti-VISTA antibody HMBD-002 reprograms tumor associated macrophages and promotes cytotoxic T cell response

    Continue Reading
    • Publications & Posters
    • Publications & Posters - 2022

    SITC 2022: Trial in Progress: A phase 1 first-in-human study of HMBD-002, an IgG4 monoclonal antibody targeting VISTA, as a monotherapy and combined with pembrolizumab in patients with advanced solid malignancies

    Continue Reading
    • Announcements
    • Announcements 2022

    Hummingbird Bioscience Announces Two HMBD-002 Poster Presentations at the Society for Immunotherapy of Cancer 2022 Annual Meeting

    Continue Reading
    • Announcements
    • Announcements 2022

    Hummingbird Bioscience to Attend the Credit Suisse 31st Annual Healthcare Conference

    Continue Reading
    • News
    • News - 2022

    New biotech facility Hummingbird Bioscience opens

    Continue Reading
    • News
    • News - 2022

    王瑞杰出席“蜂鸟”生物医药科研设施开幕:引进全球人才有助我国打造科研绿洲

    Continue Reading
    • News
    • News - 2022

    Biomed start-up Hummingbird Bioscience opens new facility to boost its R&D work

    Continue Reading
    • Announcements
    • Announcements 2022

    Hummingbird Bioscience Holds Opening Ceremony for Singapore Science Park Office and Research Facilities

    Continue Reading
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • →

Hummingbird Bioscience

TMC Innovation
2450 Holcombe Blvd, Suite X
Houston, TX 77021

The Galen
61 Science Park Road, #06-15/24,
Singapore 117525

For general enquiries, please contact contact@hummingbirdbio.com

For career enquiries, please contact careers@hummingbirdbio.com

For business development opportunities, please contact bd@hummingbirdbio.com


Hummingbird Bioscience Twitter Hummingbird Bioscience Twitter Hummingbird Bioscience LinkedinHummingbird Bioscience Linkedin Hummingbird Bioscience YouTube Hummingbird Bioscience YouTube
Subscribe to our updates
Registered Company No: 201505192N
PRIVACY POLICY | © 2022 Hummingbird Bioscience

Subscribe to our updates

    *indicates required

    GDPR Marketing Permissions

    *Please select all the ways you would like to hear from Hummingbird Bioscience:

    You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website. For questions about this mailing list, please email communications@hummingbirdbio.com

    We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.